AU2001288921A1 - Human breast cancer biomarkers - Google Patents
Human breast cancer biomarkersInfo
- Publication number
- AU2001288921A1 AU2001288921A1 AU2001288921A AU8892101A AU2001288921A1 AU 2001288921 A1 AU2001288921 A1 AU 2001288921A1 AU 2001288921 A AU2001288921 A AU 2001288921A AU 8892101 A AU8892101 A AU 8892101A AU 2001288921 A1 AU2001288921 A1 AU 2001288921A1
- Authority
- AU
- Australia
- Prior art keywords
- breast cancer
- human breast
- cancer biomarkers
- biomarkers
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23179200P | 2000-09-11 | 2000-09-11 | |
| US60/231,792 | 2000-09-11 | ||
| PCT/US2001/028133 WO2002023200A2 (en) | 2000-09-11 | 2001-09-07 | Human breast cancer biomarkers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001288921A1 true AU2001288921A1 (en) | 2002-03-26 |
Family
ID=22870662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001288921A Abandoned AU2001288921A1 (en) | 2000-09-11 | 2001-09-07 | Human breast cancer biomarkers |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001288921A1 (en) |
| WO (1) | WO2002023200A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6855554B2 (en) | 2001-09-21 | 2005-02-15 | Board Of Regents, The University Of Texas Systems | Methods and compositions for detection of breast cancer |
| EP1477803A1 (en) * | 2003-05-15 | 2004-11-17 | Europroteome AG | Serum protein profiling for the diagnosis of epithelial cancers |
| AU2004239417A1 (en) * | 2003-05-15 | 2004-11-25 | Europroteome Ag | Differential diagnosis of colorectal cancer and other diseases of the colon |
| EP1629278A1 (en) * | 2003-05-15 | 2006-03-01 | Europroteome AG | Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer |
| CA2524708C (en) | 2003-06-06 | 2009-10-06 | F. Hoffmann-La Roche Ag | Use of protein cellular retinoic acid-binding protein ii (crabp ii) as marker for breast cancer |
| CN1813190B (en) * | 2003-07-02 | 2011-06-29 | 佳能株式会社 | Information acquisition method |
| WO2005040806A2 (en) | 2003-10-15 | 2005-05-06 | Roche Diagnostics Gmbh | Use of protein asc as a marker for breast cancer |
| DE602004010432T2 (en) | 2003-12-23 | 2008-12-04 | Roche Diagnostics Gmbh | METHOD OF ASSESSING RHEUMATOID ARTHRITIS BY MEASURING ANTI-CCP AND INTERLEUKIN 6 |
| WO2010097186A1 (en) | 2009-02-24 | 2010-09-02 | Roche Diagnostic Gmbh | Use of s-erbb-3 as a marker for cancer |
-
2001
- 2001-09-07 WO PCT/US2001/028133 patent/WO2002023200A2/en active Application Filing
- 2001-09-07 AU AU2001288921A patent/AU2001288921A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002023200A2 (en) | 2002-03-21 |
| WO2002023200A3 (en) | 2003-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002212527A1 (en) | Thermometry-based breast cancer risk assessment | |
| AU2002360769A1 (en) | Breast cancer expression profiling | |
| AU2002362454A1 (en) | Regulated breast cancer genes | |
| AU2002211835A1 (en) | Oncology tissue microarrays | |
| AU2003214626A1 (en) | Breast cancer screening | |
| AU2003222604A1 (en) | Proteins involved in breast cancer | |
| AUPR395801A0 (en) | Antibodies against cancer | |
| AU2001290860A1 (en) | Spas-1 cancer antigen | |
| AU2001281652A1 (en) | Breast cover insert | |
| GB0110847D0 (en) | Breast cancer detection | |
| AU2948199A (en) | Breast cancer antigen | |
| AU2001288921A1 (en) | Human breast cancer biomarkers | |
| AU2002258597A1 (en) | Prognostic methods for breast cancer | |
| GB0005257D0 (en) | Breast cancer hormonal therapy | |
| AU2002214582A1 (en) | Breast pads | |
| AU2002362613A1 (en) | Galectins-1-and-4 in tumor development | |
| AU2002360815A1 (en) | Human breast cancer biomarkers | |
| AU2001257325A1 (en) | Cancer treatment | |
| AU2002343714A1 (en) | Breast cancer eradication program | |
| GB0026015D0 (en) | Cancer treatment | |
| AU2002358279A1 (en) | Biomarkers for breast cancer | |
| AU2001238697A1 (en) | Personal breast cancer indicator | |
| AU2002363807A1 (en) | Breast cancer associated polypeptide | |
| AU2002351382A1 (en) | Combination cancer therapy | |
| AU2001289127A1 (en) | Tumor treatment |